Showcasing Innovations at KSTI 2026: Two UNSRI Innovators Present TeleOTIVA and Secretome Stem Cell

Sriwijaya University (UNSRI) is showcasing two of its leading innovations at the 2026 Indonesian Science, Technology, and Industry Convention (KSTI). The exhibition will take place at the Sepuluh Nopember Institute of Technology (ITS) in Surabaya from November 11–13, 2026. 

The two innovations are TeleOTIVA and the Umbilical Cord Mesenchymal Stem Cell (UC-MSC) Secretome for Knee Osteoarthritis, which successfully passed the curation process by the Ministry of Higher Education, Science, and Technology (Kemdiktisaintek) as a flagship product and a breakthrough discovery from a university.

Support for the innovators was demonstrated directly by the Rector of UNSRI, Prof. Dr. Taufiq Marwa, S.E., M.Si., who attended the opening of KSTI 2026 on Wednesday (November 11, 2026). The Rector was accompanied by the Vice Rector for Academic Affairs, Student Affairs, and Quality Assurance, Prof. Dr. Ir. H. Rujito Agus Suwignyo, M.Agr., as well as the Vice Rector for Finance, Resources, Procurement, and Logistics, Prof. Dr. Bernadette Robiani, M.Sc.

Following the opening ceremony, UNSRI’s leadership participated in a series of activities, toured the UNSRI innovation exhibition booths, and engaged in dialogue with the innovators. 

The first innovation was TeleOTIVA (Telemedicine and IVA Automation), developed by Prof. Dr. Ir. Siti Nurmaini, M.T., a lecturer in the Faculty of Computer Science and Director of Innovation and Commercialization at UNSRI. TeleOTIVA is an artificial intelligence (AI)-based application designed to help healthcare workers interpret the results of cervical precancer screening using the Acetic Acid Visual Inspection (IVA) method automatically, quickly, and accurately. 

Meanwhile, the second innovation is the Umbilical Cord Mesenchymal Stem Cell (UC-MSC) Secretome for Knee Osteoarthritis, developed by Prof. Dr. dr. Radiyati Umi Partan, Sp.PD-KR, M.Kes., a professor at the Faculty of Medicine and Vice Rector for Research, Community Service, Innovation, Commercialization, and Information Technology at UNSRI. This innovation was developed as a regenerative therapy that utilizes bioactive molecules from umbilical cord stem cells to help reduce inflammation and support joint tissue repair in patients with knee osteoarthritis.

Both represent UNSRI’s research strengths in the health sector, ranging from artificial intelligence technology to regenerative therapy.

For your information, KSTI 2026 carries the theme “Accelerating Indonesia’s Economic Self-Reliance and Well-being.” This national and international forum brings together more than 3,000 participants, ranging from scientists, technocrats, SOE leaders, strategic industry players, and policymakers to members of the Indonesian diaspora from various countries.

Prof. Siti Nurmaini was present in person to introduce TeleOTIVA to exhibition visitors. She explained that this innovation emerged from a collaboration between the Intelligent Systems Research Group at the UNSRI Faculty of Computer Science and obstetrics and gynecology consultants from the UNSRI Faculty of Medicine and RSMH Palembang.

“Cervical cancer screening coverage in Indonesia remains low, partly due to a shortage of trained personnel at primary-care health facilities. With TeleOTIVA, IVA results can be automatically interpreted in a matter of seconds, allowing screening to reach more women. Through KSTI, we aim to expand our partnerships so that TeleOTIVA can be widely adopted in healthcare services as soon as possible,” she explained.

UNSRI Rector, Prof. Dr. Taufiq Marwa, S.E., M.Si., expressed his pride in the opportunity for the work of UNSRI’s academic community to be showcased at such a strategic national and international forum.

“We are proud that innovations by UNSRI faculty members can be showcased at a forum as significant as KSTI. TeleOTIVA and the stem cell secretome are proof that UNSRI’s research doesn’t stop in the laboratory but produces products ready to benefit society. We are here to fully support these innovators, and we hope this exhibition opens up opportunities for commercialization in collaboration with industry and investors,” said the Rector.

The Rector added that UNSRI will continue to foster impactful innovations. “Moving forward, we want to see even more works by UNSRI’s academic community showcased at the national and international levels and contributing to the nation’s self-reliance,” he added.

In addition to participating in the exhibition, UNSRI innovators also took part in the Inventor, Innovator, Investor Forum and a networking dinner on Thursday (November 12, 2026). These two events served as platforms to explore partnerships and opportunities for commercializing innovative products with industry partners and investors. (Kris_Humas)